U.S. Markets closed
  • S&P 500

    3,841.94
    +73.47 (+1.95%)
     
  • Dow 30

    31,496.30
    +572.16 (+1.85%)
     
  • Nasdaq

    12,920.15
    +196.68 (+1.55%)
     
  • Russell 2000

    2,192.21
    +45.29 (+2.11%)
     
  • Crude Oil

    66.28
    +2.45 (+3.84%)
     
  • Gold

    1,698.20
    -2.50 (-0.15%)
     
  • Silver

    25.30
    -0.17 (-0.65%)
     
  • EUR/USD

    1.1916
    -0.0063 (-0.5243%)
     
  • 10-Yr Bond

    1.5540
    +0.0040 (+0.26%)
     
  • Vix

    24.66
    -3.91 (-13.69%)
     
  • GBP/USD

    1.3834
    -0.0060 (-0.4344%)
     
  • USD/JPY

    108.3600
    +0.3840 (+0.3556%)
     
  • BTC-USD

    50,839.23
    +3,244.45 (+6.82%)
     
  • CMC Crypto 200

    982.93
    +39.75 (+4.21%)
     
  • FTSE 100

    6,630.52
    -20.36 (-0.31%)
     
  • Nikkei 225

    28,864.32
    -65.79 (-0.23%)
     

A Look Into Healthcare Sector Value Stocks

  • Oops!
    Something went wrong.
    Please try again later.
Benzinga Insights
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

What is a Value Stock?

A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued.

Benzinga Insights has compiled a list of value stocks in the healthcare sector that may be worth watching:

  1. Jaguar Health (NASDAQ:JAGX) - P/E: 0.86

  2. Geovax Labs (NASDAQ:GOVX) - P/E: 0.01

  3. Innoviva (NASDAQ:INVA) - P/E: 5.99

  4. OpGen (NASDAQ:OPGN) - P/E: 0.71

  5. Bio-Rad Laboratories (NYSE:BIO) - P/E: 5.25

Jaguar Health saw an increase in earnings per share from -0.44 in Q2 to -0.21 now. Jaguar Health does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.

Geovax Labs saw a decrease in earnings per share from -0.03 in Q2 to -0.73 now. Geovax Labs does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.

This quarter, Innoviva experienced an increase in earnings per share, which was 0.26 in Q3 and is now 0.48. Innoviva does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.

OpGen's earnings per share for Q3 sits at -0.4, whereas in Q2, they were at -0.49. OpGen does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.

Bio-Rad Laboratories saw an increase in earnings per share from 3.0 in Q3 to 4.01 now. Bio-Rad Laboratories does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.

The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.